INTRODUCTION
============

In our material world, everyone faces the dilemma of what to keep and discard as priorities and needs change over time. It is an easy metaphor to compare the accumulation of possessions by a household to the accumulation of genes within a genome; however, the forces of natural selection are extemporaneous and cannot plan for the future. Nonetheless, the underlying molecular systems that continually edit a genome will themselves be affected by successes and failures that occur only after the passage of time. Genes and other genetic elements can be sorted, deleted, retained, and regulated within a genome in a way that maximizes survivorship in the future. This is the concept briefly explored here, using the example of effector proteins from filamentous plant pathogens that interact with host plant immune systems.

WHY DO PATHOGENS HAVE Avr FACTORS?
==================================

Plant pathogen effector proteins represent finely tuned instruments of infection that are crucial to the parasitic lifestyle ([@B12]; [@B26]). Effectors establish conditions that permit pathogenic organisms to grow and reproduce on their hosts. But an asset can become a liability when host plant immune systems evolve recognition capabilities that home in on effectors as triggers to activate robust defense responses that arrest pathogen growth ([@B3]). In such cases of effector triggered immunity (ETI), the pathogen effector responsible for host immune activation is known as an avirulence (Avr) factor ([@B4]). Pathogen Avr factors always raise simplistic questions when they are introduced to students of plant pathology. Why do pathogens possess Avr factors, since they are self-defeating? Why haven't all the Avr factors been eliminated by natural selection? The answers of course hinge on the conditionality of ETI and on the utility of Avr factors in circumstances where they escape host immune recognition systems.

GAIN OF VIRULENCE IS ESCAPE FROM IMMUNITY
=========================================

When a pathogen effector comes under host immune surveillance, the corresponding *Avr* gene needs to change in some way, so that the Avr factor no longer causes ETI, in order for the pathogen to grow and reproduce on hosts with the enhanced immune capability. The necessary gain of virulence changes will depend on how the host immune system interacts with the effector ([@B32]). Conventional mutations to *Avr* genes that result in gain of virulence are exceedingly diverse ([@B5]; [@B33]; [@B35]; [@B24]; [@B15]; [@B14]; [@B40]). Pseudogenization due to interruption of the *Avr* open reading frame and wholesale *Avr* gene losses are common. This observation points to the dispensability of individual *Avr* genes and suggests that pathogen effector arsenals have a built-in redundancy. Provided that an Avr factor is retained by some individuals within a pathogen population, sub-populations or lineages can apparently lose and recover *Avr* genes repeatedly, as circumstances warrant. For example, in an asexually recombining population of a fungal pathogen, deleted *Avr* genes can be regained from other members of the same population ([@B2]). There are also numerous examples of gain of virulence changes to pathogen *Avr* genes that are accomplished without any nucleotide changes whatsoever occurring within the open reading frame ([@B16]; [@B29]; [@B21]; [@B7]; [@B6]; [@B9]; [@B20]; [@B1]; [@B19]). This can occur by epiallelic variation or by conventional mutations to *cis*-elements or flanking sequences that provide regulatory control of *Avr* gene transcription or translation, or possibly by changes to trans-acting elements, such as transcription- or epigenetic-factors that control *Avr* gene expression.

NATURALLY OCCURRING REVERSIBLE SYSTEMS FOR *Avr* EXPRESSION STATES
==================================================================

Gain of virulence changes that leave the open reading frame of the *Avr* gene itself unchanged may be more easily reversible, should appropriate conditions occur for the re-deployment of an *Avr* allele that has been suppressed or wiped out of the population through a selective sweep. Epigenetic systems that regulate transcription offer powerful and versatile means for reversibly controlling effector gene expression states depending on environmental conditions. For example, experiments suggest that histone H3 lysine 9 (H3K9) methylation plays an role in coordinating the expression of hundreds of effectors in a fungal plant pathogen ([@B30]). Epigenetic control of effector genes could arise in various ways, such as by recruiting existing systems that regulate the transcription and proliferation of mobile genetic elements or transposons ([@B28]; [@B18]; [@B42]). This model is illustrated in **Figure [1](#F1){ref-type="fig"}**. Ancient epigenetic systems that release and silence transposons are proposed to contribute to genome plasticity and to be vitally important to evolutionary adaptation ([@B8]). Whole genome sequencing of filamentous plant pathogens has provided good examples demonstrating that effectors and other genes associated with pathogenicity, host-range, and virulence are often embedded in repetitive, transposon-rich segments ([@B34]; [@B11]; [@B31]). The positioning of effector genes in such regions is advantageous because it facilitates duplication, recombination, and mutational mechanisms that lead to variation and often underlie gain of virulence changes ([@B36]; [@B25]; [@B23]). The close association with transposons could have allowed effector genes to co-opt or capture epigenetic switches dedicated to regulating the mobile genetic elements ([@B39]). There is also evidence indicating that epigenetic regulators themselves can be highly polymorphic and positioned in repetitive, transposon-rich segments, suggesting adaptive interplay between conventional- and epigenetic variations in plant pathogens ([@B22]).

![**A model illustrating how epigenetic control systems dedicated to transposon regulation may be shared or co-opted by pathogen effectors.** Events that have the potential to perturb the epigenetic stasis could alter transposon activity or avirulence (*Avr*) gene expression, leading to changes in genome organization or virulence, respectively. Active transposons or expressed *Avr* effectors are shown as bold arrows; silenced transposons and *Avr* effectors are shown with dashed lines and an asterisk (\*).](fpls-05-00638-g001){#F1}

Conceptually, the flexible nature of epigenetic control appears tailor-made for pathogen *Avr* effector genes, as illustrated in **Figure [2](#F2){ref-type="fig"}**. Spontaneous changes in *Avr* gene expression states have been experimentally observed ([@B19]) and could help to account for previous descriptions of variation in virulence of clonal isolates in the laboratory ([@B27]) or in the field ([@B10]; [@B13]). Historically, plant pathologists have always struggled to explain changes in virulence of pathogen populations, and have noted that as specific gain of virulence changes accumulate in a pathogen strain, it loses general fitness or aggressiveness ([@B38]; [@B41]).

![**A hypothetical timeline demonstrating how epigenetic regulation of pathogen avirulence (*Avr*) genes could respond to host resistance (*R*) gene selection pressure.** Reversible expression changes could result in recycling or reuse of *Avr* genes by pathogen populations, as shown in this illustration. Changes in plant *R*-gene selective pressure can result from genetic drift or cultivation practices. The complement of expressed effector genes, necessary to evade immunity with a minimum fitness penalty, is shown below for the pathogen. Expressed *Avr* effectors are shown as bold arrows; gene-silenced *Avr* effectors are shown with dashed lines and an asterisk (\*).](fpls-05-00638-g002){#F2}

Epigenetic switching of expression allows the pathogen to respond successfully to new immune capabilities of the host while retaining *Avr* genes for future use, if necessary. For example, host immunity in natural or cultivated plant populations may change as a result of genetic drift or agronomic practices. An immune receptor encoded by a host resistance (*R*) gene can be easily lost or mutated, or fall in to disuse, in the absence of any selective pressure or economic advantage, especially so if there is a fitness cost. The pathogen could also jump to a new host, or be introduced to a new environment, where the Avr factor does not face the challenge of host immune recognition. Under such circumstances, re-activating or recycling previous *Avr* effector genes could impart a fitness benefit that aids pathogen growth and reproduction.

EPIALLELIC VARIATION OF *Avr* GENE EXPRESSION PRESENTS PRACTICAL PROBLEMS
=========================================================================

Most troublesome to plant breeders is that epigenetic variation in *Avr* gene expression allows pathogens to adapt rapidly and recycle effectors after a selective sweep imposed by cultivar specific *R*-gene deployment. Epiallelic variation of *Avr* effector gene expression also presents diagnostic and detection problems for plant pathologists aiming to develop pathotype-specific tests for better tracking, management, and control of plant disease causing organisms. This is significant because molecular tools are currently driving advances in plant breeding and pathogen diagnostics, as breeders, pathologists, inspectors, and regulators increasingly rely on genetic information for their decision making. Sequence data can be helpful in characterizing pathogen strains from the field and predicting the risk of *R*-gene failure ([@B37]) but genetic tests based on DNA sequences do not have the capability to detect expression differences. Testing a gene expression state is more technically demanding and requires greater skill, time, and resources; it is not a test that is routinely performed by diagnostic laboratories. Perhaps inexpensive and efficient detection systems will be developed and applied to this problem in the future, such as for RNA molecules, or DNA or protein modifications that could underlie epigenetic variation. Until this occurs it does not seem likely that simple tests will be available for pathotyping strains that vary epigenetically in *Avr* gene expression. Traditional pathotyping relies on isolation, culturing, and phenotyping pathogen strains by inoculation on a set of plant lines carrying different *R*-genes. This demands considerable time and expertise, and requires plants, growth facilities, and other materials dedicated to each disease causing organism. The result is that strain pathotyping is usually done only by research laboratories that are specialized towards a particular organism or are well-versed in the proper bioassay.

CONCLUSION
==========

This perspective introduces the concept of epigenetic variation of effector expression in plant pathogens. It is a newly discovered phenomenon that is still in the early stages of being characterized. Epigenetic variation contributes to phenotypic diversity and host adaptation and helps to explain how disease causing and invasive organisms rapidly adapt to changing host and environmental conditions ([@B17]). The prevalence of epigenetic variation, its mechanistic control, its relative importance to particular plant pathogen species, and its interplay with conventional genetic variation all require further work to define. Are the known and proposed examples of epigenetic variation within plant pathogens unusual and rare curiosities, or do they point to a more widespread biological phenomenon with evolutionary implications that have been long overlooked or undetected? Many scientists suspect the latter may be true, but it is a question that deserves a clear answer. There are potentially wide-ranging consequences affecting disease management and diagnostics that arise from epigenetic control of *Avr* genes and other host-range determinants. This should spur additional research in the area, which can only be helpful for controlling plant diseases that are damaging to crops, ornamental plants, and natural environments.
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